Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/30/2002 | US20020064799 Proteomic analysis |
05/30/2002 | US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles |
05/30/2002 | US20020064790 Generating nucleotide sequence binding ligand; obtain ligandthat binds to nucleotide sequence, monitor binding activity of particle and sequences, recover ligands that utilizes reduced energy to bind sequences compare to wild type |
05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
05/30/2002 | US20020064777 Recombination repair gene, MIM, from arabidopsis thaliana |
05/30/2002 | US20020064772 In-situ methods for analyzing target sequences using linear beacons |
05/30/2002 | US20020064770 Detecting preferential receptor associating protein; obtain library, incubate with receptor, detect bound receptor complex, isolate receptor associating protein |
05/30/2002 | US20020064543 Highly specific insecticidal toxin comprising 45 residues and three intramolecular disulfide bonds; selecting potent inhibitors of insect calcium channels. |
05/30/2002 | US20020064539 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog |
05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
05/30/2002 | US20020064534 Herpesvirus preparations and their uses |
05/30/2002 | US20020064533 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
05/30/2002 | US20020064532 Virus mutant of given nucleotide sequence; vaccine can be administered to poultry by mass application routes |
05/30/2002 | US20020064531 P28 gene family, may be involved in immune avoidance; DNA sequences, proteins, antibodies; use in vaccines against E. chaffeensis |
05/30/2002 | US20020064530 Variants of phleum pratense allergenic proteins |
05/30/2002 | US20020064525 Anti-IgE vaccines |
05/30/2002 | US20020064523 SynMuv genes act as negative regulators of nematode Caenorhabditis elegans signalling pathway; tumor suppressor proteins; nucleic acids, proteins, antibodies; diagnosis of proliferative disorders |
05/30/2002 | US20020064521 Nucleic acids coding for both A and B chains of human p53, human leukocyte antigen(HLA) restricted murine T-cell receptor (TCR); transformed CD8+ cytotoxic T lymphocytes for immunotherapy of tumors that over-express p53 |
05/30/2002 | US20020064501 Determining peptide's therapeutic effect by administering to subject prone to showing signs of diabetes; determining development of diabetes |
05/30/2002 | CA2439184A1 Aspergillus fumigatus cofilin |
05/30/2002 | CA2439164A1 Aspergillus fumigatus profilin |
05/30/2002 | CA2430275A1 Human v2 vomeronasal receptor |
05/30/2002 | CA2429860A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
05/30/2002 | CA2429856A1 Adapter protein and gene encoding it |
05/30/2002 | CA2429712A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
05/30/2002 | CA2429579A1 Truncated cd200 |
05/30/2002 | CA2429576A1 Fungal gene cluster associated with pathogenesis |
05/30/2002 | CA2428979A1 Human erg2 potassium channel |
05/30/2002 | CA2426939A1 Cystoskeleton-associated proteins |
05/30/2002 | CA2426477A1 Compositions, methods and kits relating to remodelin |
05/30/2002 | CA2421151A1 Modified vaccinia ankara virus variant |
05/30/2002 | CA2363951A1 Modulating ramp activity |
05/29/2002 | EP1209237A2 Synthetic DNA sequence having enhanced insecticidal activity in maize |
05/29/2002 | EP1209235A1 Expression vector for fusion gene and method for producing immobilized enzyme |
05/29/2002 | EP1209232A1 Gene regulating plant branching, vector containing the gene, microorganism transformed by the vector, and method for regulating plant branching by using the microorganism |
05/29/2002 | EP1209231A1 Meg-1 protein |
05/29/2002 | EP1209230A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
05/29/2002 | EP1209229A1 Gene involved in schizophrenia |
05/29/2002 | EP1209168A1 Polypeptides and nucleic acids encoding the same |
05/29/2002 | EP1209167A1 Method of producing a biosensor protein capable of regulating a fluorescence property of the modified green fluorescent protein therein, and the biosensor protein produced by the method |
05/29/2002 | EP1208384A2 Methods and compositions for modulating oxidized ldl transport |
05/29/2002 | EP1208381A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
05/29/2002 | EP1208380A2 Cancer associated antigens and uses therefor |
05/29/2002 | EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
05/29/2002 | EP1208215A2 Plant defensin variants with modified cystein residues |
05/29/2002 | EP1208214A2 Genetically engineered bleb vaccine |
05/29/2002 | EP1208212A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
05/29/2002 | EP1208210A2 Archaeal replication accessory factors and methods of use |
05/29/2002 | EP1208207A2 Method for producing a channel-forming protein |
05/29/2002 | EP1208206A2 Moraxella catarrhalis antigen basb121 |
05/29/2002 | EP1208204A2 Plant reproduction proteins |
05/29/2002 | EP1208202A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
05/29/2002 | EP1208200A2 Transgenic animal model for neurodegenerative diseases |
05/29/2002 | EP1208199A2 DNA CODING FOR $g(b)-TUBULIN AND USE THEREOF |
05/29/2002 | EP1208198A2 Egfh2 genes and gene products |
05/29/2002 | EP1208197A1 Iren protein, its preparation and use |
05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
05/29/2002 | EP1208195A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2002 | EP1208194A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
05/29/2002 | EP1208192A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
05/29/2002 | EP1208116A2 Somatostatin analogs, radiolabelled derivatives thereof and their use |
05/29/2002 | EP1208115A2 Feline interleukin-12 as an immune stimulant |
05/29/2002 | EP1208114A2 Induction of programmed cell death by n5 gene |
05/29/2002 | EP1208112A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene |
05/29/2002 | EP1208111A2 Genes encoding insect odorant receptors and uses thereof |
05/29/2002 | EP1207909A2 Method for coupling molecules |
05/29/2002 | EP1207905A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
05/29/2002 | EP1207889A1 Vaccine to control equine protozoal myeloencephalitis in horses |
05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
05/29/2002 | EP1207751A1 Non-mammalian transgenic animal model for cellular proliferative diseases |
05/29/2002 | EP1207736A1 Method for induction synthesis of heat stress proteins (hsp) & production from herbaceous plants |
05/29/2002 | EP1002095B1 Improved protein expression strains |
05/29/2002 | EP0938329B1 Immunogenic tlp composition |
05/29/2002 | EP0889971B1 Phosphatase modulator |
05/29/2002 | EP0736027B1 Guanine synthons for peptide nucleic acid synthesis and method for production |
05/29/2002 | EP0665955B1 Particles having gelatin-aminodextran coatings of and processes for making same |
05/29/2002 | EP0573544B1 Intestinal trefoil proteins |
05/29/2002 | DE10055886A1 Impfstoffe, die rekombinante Hantavirusproteine enthalten, Verfahren zu iher Herstellung und ihre Verwendung Vaccines containing recombinant Hantavirusproteine, process for preparation and their use IHER |
05/29/2002 | DE10054074A1 Diagnosis and treatment of neuroectodermal tumors, by detecting a splice variant of noradrenaline transporter or by modulating transporter activity |
05/29/2002 | CN1351713A Diagnosis and treatment of atherosclerosis and coronary heart disease |
05/29/2002 | CN1351669A Chimeric promoters based on the plastocyanin PETE promoter from pea |
05/29/2002 | CN1351667A Transgenic plants that are resistant to a broad specrum of pathogens |
05/29/2002 | CN1351664A DNA sequence and recombination production of a graminae allergen |
05/29/2002 | CN1351663A Viral variants |
05/29/2002 | CN1351661A Compounds |
05/29/2002 | CN1351660A directed evolution of microorganisms |
05/29/2002 | CN1351653A Anti-bacterial vaccine compositions |
05/29/2002 | CN1351613A Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity |
05/29/2002 | CN1351612A Novel organic anion transport proteins |
05/29/2002 | CN1351611A Long lasting fusion peptide inhibitors of viral infection |
05/29/2002 | CN1351505A Short-chain peptide dye conjagates used as contrast agents for optical diagnostics |
05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
05/29/2002 | CN1351174A Inhibiting material for inverting enzyme for angiotensin I |
05/29/2002 | CN1351083A Process for preparing collagen |
05/29/2002 | CN1351082A Human protein with cancer cell growth promoting function and its coding sequence |